Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-24

Clinical Trial Update: A Teleheath tDCS Approach to Decrease Cannabis Use [Phase 2]

View source ↗

Summary

Phase 2 trial results for a telehealth transcranial direct current stimulation (tDCS) approach to reduce cannabis use in individuals with Cannabis Use Disorder,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: NYU Langone Health | Conditions: Cannabis Use Disorder, Multiple Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2025-06-24